May 1, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 252 shares of Abrdn Life Sciences Investors at $13.02 per share, a transaction worth $3.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.